That's pretty astonishing! No wonder the attendees at the conference were so attentive, thalio!
And yet all our company said in its PR was: ". . . the company's proprietary ssDNA technology is effective in preventing the growth of bacteria such as the strains that cause sepsis and other potentially fatal diseases."
So I'd hope that when Chen's article comes out -- which the 11/13 PR says will be "in the next few weeks" -- it'll create the same kind of stir the article about the new class of antibiotics did when it was published in Science.